H.B. No. 2677 aims to enhance Medicaid coverage and reimbursement for obesity treatment and diabetes prevention services in Texas. The bill introduces two new sections to the Human Resources Code: Section 32.02461, which outlines reimbursement for obesity treatment, and Section 32.02462, which addresses reimbursement for diabetes prevention program services. Under Section 32.02461, the bill defines key terms such as "anti-obesity medication," "intensive behavioral therapy," and "metabolic and bariatric surgery," and mandates that the Texas Health and Human Services Commission ensure reimbursement for these services when provided to Medicaid recipients. It also establishes criteria for medical necessity regarding anti-obesity medications and allows for the use of telehealth services.

Section 32.02462 focuses on diabetes prevention programs, ensuring that Medicaid reimbursement is available for services provided by recognized program suppliers to eligible recipients. The bill stipulates that recipients must meet specific eligibility requirements and have not previously participated in the program while receiving Medicaid. Additionally, it allows for utilization management to determine medical necessity for these services, similar to other healthcare services under the Medicaid program. The bill includes provisions for state agencies to seek necessary federal waivers before implementation and requires the Health and Human Services Commission to notify recipients about the availability of obesity treatment options once the new provisions are in effect.

Statutes affected:
Introduced: ()
House Committee Report: ()